Total Costs & Expenses

$4.68B

TTM · Period ending: Jun 30, 2026 · USD

EW Total Costs & Expenses

Latest reported$4.68Bperiod endingJun 30, 2026

EW TTM Total Costs & Expenses ($730.00M → $4.68B)

TTM Total Costs & Expenses

High-resolution chart · PNG

EW total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edwards Lifesciences Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2026	4,682,700,000
Mar 31, 2026	4,562,500,000
Dec 31, 2025	4,446,500,000
Sep 30, 2025	4,320,400,000
Jun 30, 2025	4,196,200,000
Mar 31, 2025	4,116,100,000
Dec 31, 2024	4,072,600,000
Sep 30, 2024	3,909,100,000
Jun 30, 2024	3,802,200,000
Mar 31, 2024	3,705,900,000
Dec 31, 2023	3,788,300,000
Sep 30, 2023	3,817,400,000
Jun 30, 2023	3,812,300,000
Mar 31, 2023	3,832,900,000
Dec 31, 2022	3,681,600,000
Sep 30, 2022	3,710,700,000
Jun 30, 2022	3,721,900,000
Mar 31, 2022	3,701,800,000
Dec 31, 2021	3,622,100,000
Sep 30, 2021	3,483,600,000
Jun 30, 2021	3,370,500,000
Mar 31, 2021	3,148,900,000
Dec 31, 2020	3,090,300,000
Sep 30, 2020	3,097,900,000
Jun 30, 2020	3,115,500,000
Mar 31, 2020	3,227,900,000
Dec 31, 2019	3,152,100,000
Sep 30, 2019	3,002,700,000
Jun 30, 2019	2,846,400,000
Mar 31, 2019	2,691,700,000
Dec 31, 2018	2,630,500,000
Sep 30, 2018	2,590,000,000
Jun 30, 2018	2,542,300,000
Mar 31, 2018	2,467,800,000
Dec 31, 2017	2,413,500,000
Sep 30, 2017	2,325,200,000
Jun 30, 2017	2,262,300,000
Mar 31, 2017	2,219,500,000
Dec 31, 2016	2,139,000,000
Sep 30, 2016	2,076,600,000
Jun 30, 2016	1,995,700,000
Mar 31, 2016	1,921,500,000
Dec 31, 2015	1,851,000,000
Sep 30, 2015	1,822,100,000
Jun 30, 2015	1,840,300,000
Mar 31, 2015	1,826,100,000
Dec 31, 2014	1,830,100,000
Sep 30, 2014	1,777,200,000
Jun 30, 2014	1,693,600,000
Mar 31, 2014	1,632,700,000
Dec 31, 2013	1,591,000,000
Sep 30, 2013	1,555,000,000
Jun 30, 2013	1,514,000,000
Mar 31, 2013	1,505,300,000
Dec 31, 2012	1,491,200,000
Sep 30, 2012	1,456,300,000
Jun 30, 2012	1,455,800,000
Mar 31, 2012	1,425,500,000
Dec 31, 2011	1,378,500,000
Sep 30, 2011	1,346,600,000
Jun 30, 2011	1,275,300,000
Mar 31, 2011	1,211,000,000
Dec 31, 2010	1,162,700,000
Sep 30, 2010	1,133,200,000
Jun 30, 2010	1,120,800,000
Mar 31, 2010	1,102,200,000
Dec 31, 2009	1,083,200,000
Sep 30, 2009	1,055,700,000
Jun 30, 2009	1,045,900,000
Mar 31, 2009	1,047,800,000
Dec 31, 2008	1,051,100,000
Sep 30, 2008	1,043,900,000
Jun 30, 2008	1,009,400,000
Mar 31, 2008	960,000,000
Dec 31, 2007	917,400,000
Sep 30, 2007	892,300,000
Jun 30, 2007	874,700,000
Mar 31, 2007	870,800,000
Dec 31, 2006	842,300,000
Sep 30, 2006	822,300,000
Jun 30, 2006	815,900,000
Mar 31, 2006	806,500,000
Dec 31, 2005	822,000,000
Sep 30, 2005	816,800,000
Jun 30, 2005	805,500,000
Mar 31, 2005	787,400,000
Dec 31, 2004	792,500,000
Sep 30, 2004	780,200,000
Jun 30, 2004	764,900,000
Mar 31, 2004	757,500,000
Dec 31, 2003	725,400,000
Sep 30, 2003	712,500,000
Jun 30, 2003	745,000,000
Mar 31, 2003	700,000,000
Dec 31, 2002	651,900,000
Sep 30, 2002	612,700,000
Jun 30, 2002	530,500,000
Mar 31, 2002	634,500,000
Dec 31, 2001	668,000,000
Sep 30, 2001	705,600,000